Stocks analysis

Analysis for IBM

  • 📈 Growth — 18/30
  • 💰 Profitability — 15/20
  • 🏦 Financial Health — 12/20
  • 💵 Valuation — 14/20
  • ⚠️ Risk — 6/10
Overall Score: 55/100

Summary:


📈 Growth & Financial Trajectory

IBM shows an 8-quarter cycle with revenue rising from about $14.46B in 2024 Q1 to about $15.92B in 2026 Q1, a gain of roughly $1.46B (~10%) despite volatility. Net income starts near $1.61B, dips into a small loss in 2024 Q2, then recovers to the $2B+ range in several quarters, but ends around $1.22B in 2026 Q1, signaling durable earnings but modest growth.

💰 Margins & Cash Flow

  • Gross margin remains in the mid-to-high 50s percent across quarters, with margins around 53-60% in most periods.
  • Operating margin fluctuates, but cash from operations stays robust; quarterly cash from operating activities is generally positive (peaking around $4.3B–$5.2B in late 2024–2026).
  • Cash flow from investing is often negative, reflecting capital allocation; financing activity varies seasonally.

🛡️ Balance Sheet & Liquidity

Total assets near $156B; liabilities near $123B; equity around $33B. Current assets about $31.9B vs. current liabilities about $40.1B (current ratio ~ 0.8). Noncurrent liabilities around $83B; balance sheet is asset-heavy but liquidity is modest; ongoing operating cash flow supports resilience.

⚠️ Key Drivers & Risks

  • Drivers: Enterprise IT modernization and AI/Data Center demand; cloud/services
  • Risks: Cyclical IT spending and valuation sensitivity given leverage; currency exposure